PE20040584A1 - Nuevos analogos de adenosina - Google Patents
Nuevos analogos de adenosinaInfo
- Publication number
- PE20040584A1 PE20040584A1 PE2003000640A PE2003000640A PE20040584A1 PE 20040584 A1 PE20040584 A1 PE 20040584A1 PE 2003000640 A PE2003000640 A PE 2003000640A PE 2003000640 A PE2003000640 A PE 2003000640A PE 20040584 A1 PE20040584 A1 PE 20040584A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- alkylene
- cyclopentan
- purin
- fluoromethyl
- Prior art date
Links
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical class C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- -1 ALLYL Chemical class 0.000 abstract 2
- VCVOSERVUCJNPR-UHFFFAOYSA-N cyclopentane-1,2-diol Chemical compound OC1CCCC1O VCVOSERVUCJNPR-UHFFFAOYSA-N 0.000 abstract 2
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 208000001145 Metabolic Syndrome Diseases 0.000 abstract 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Emergency Medicine (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I DONDE W ES N, NàO, CH; Q ES CH2, O; R1 ES H, ALQUILO C1-C10, ALILO, 2- METILALILO, ENTRE OTROS; T ES ALQUILO C1-C10, CICLOALQUILO C1-C10, ARIL-(ALQUILENO C1-C10)-, ENTRE OTROS; A ES H, ALQUILO C1-C10, HIDROXI-(ALQUILENO C1-C10)-, ENTRE OTROS; B ES H, ALQUILO C1-C10, HIDROXI-(ALQUILENO C1-C10)-, ENTRE OTROS; X ES (A) o (B); n Y p SON CADA UNO 0-3; Y ES H, ALQUILO C1-C10, ARILO, HETEROCICLILO, ENTRE OTROS; E ES O, S. SON COMPUESTOS PREFERIDOS: (1R,2S,3R,5S)-3-{6-[1-(3-CLOROFENIL-1-IL)-PIRROLIDIN-3(S)-ILAMINO]-PURIN-9-IL}-5-FLUOROMETILCICLOPENTAN-1,2-DIOL Y (1R,2S,3R,5S)-3-{6-[(R)-1-(3-CLOROTIOFEN-2-ILMETIL)-PROPILAMINO]-PURIN-9-IL}-5-FLUOROMETILCICLOPENTAN-1,2-DIOL, ENTRE OTROS. SE REFIERE TAMBIEN A UNA PREPARACION FARMACEUTICA. DICHOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE DIABETES TIPO 2, SINDROME METABOLICO, TRASTORNOS LIPIDICOS O ENFERMEDADES CARDIOVASCULARES
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02014324A EP1375508A1 (en) | 2002-06-27 | 2002-06-27 | N6-substituted adenosine analogues and their use as pharmaceutical agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20040584A1 true PE20040584A1 (es) | 2004-11-03 |
Family
ID=29716849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2003000640A PE20040584A1 (es) | 2002-06-27 | 2003-06-25 | Nuevos analogos de adenosina |
Country Status (19)
| Country | Link |
|---|---|
| EP (2) | EP1375508A1 (es) |
| JP (1) | JP2006501178A (es) |
| KR (1) | KR20050014888A (es) |
| CN (1) | CN1671728A (es) |
| AR (1) | AR039697A1 (es) |
| AU (1) | AU2003280141A1 (es) |
| BR (1) | BR0312428A (es) |
| CA (1) | CA2490253A1 (es) |
| HR (1) | HRP20041209A2 (es) |
| IL (1) | IL165934A0 (es) |
| MA (1) | MA27465A1 (es) |
| MX (1) | MXPA04012815A (es) |
| NO (1) | NO20050398L (es) |
| PE (1) | PE20040584A1 (es) |
| PL (1) | PL375197A1 (es) |
| RU (1) | RU2005101872A (es) |
| TW (1) | TW200500376A (es) |
| WO (1) | WO2004003002A1 (es) |
| ZA (1) | ZA200410062B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS51680B (sr) | 2005-09-21 | 2011-10-31 | Pfizer Limited | Derivati karboksamida kao antagonisti receptora muskarina |
| JP2007153789A (ja) * | 2005-12-05 | 2007-06-21 | Mitsui Chemicals Inc | 光学活性３−アミノピロリジン誘導体の製造方法 |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| US8933024B2 (en) | 2010-06-18 | 2015-01-13 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
| EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| CN119039201A (zh) * | 2024-07-19 | 2024-11-29 | 苏州汉德创宏生化科技有限公司 | 一种(s)-1-叔丁氧羰基-3-氨基吡咯烷的合成方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1545645A1 (de) * | 1965-12-06 | 1969-08-21 | Boehringer Mannheim Gmbh | Verfahren zur Herstellung von disubstituierten Adenosin-Derivaten |
| AU575438B2 (en) * | 1984-10-26 | 1988-07-28 | Warner-Lambert Company | N6 - substituted deoxyribose analogues of adenosines |
| US4755594A (en) * | 1986-01-31 | 1988-07-05 | Warner-Lambert Company | N6 -substituted adenosines |
| AU8276187A (en) * | 1986-10-31 | 1988-05-25 | Warner-Lambert Company | Selected n6-substituted adenosines having selective a2 binding activity |
| WO1997033591A1 (en) * | 1996-03-13 | 1997-09-18 | Novo Nordisk A/S | A method of treating disorders related to cytokines in mammals |
| UA51716C2 (uk) * | 1996-07-08 | 2002-12-16 | Авентіс Фармасьютікалз Продактс Інк. | Сполуки, що мають гіпотензивну, кардіопротекторну, анти-ішемічну та антиліполітичну властивості, фармацевтична композиція та способи лікування |
| US6376472B1 (en) * | 1996-07-08 | 2002-04-23 | Aventis Pharmaceuticals, Inc. | Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| EP0983768A1 (en) * | 1997-05-23 | 2000-03-08 | Nippon Shinyaku Co., Ltd. | Medicinal composition for prevention or treatment of hepatopathy |
| GB9723566D0 (en) * | 1997-11-08 | 1998-01-07 | Glaxo Group Ltd | Chemical compounds |
| GB9723589D0 (en) * | 1997-11-08 | 1998-01-07 | Glaxo Group Ltd | Chemical compounds |
-
2002
- 2002-06-27 EP EP02014324A patent/EP1375508A1/en not_active Withdrawn
-
2003
- 2003-06-18 AR ARP030102151A patent/AR039697A1/es unknown
- 2003-06-25 PE PE2003000640A patent/PE20040584A1/es not_active Application Discontinuation
- 2003-06-26 HR HR20041209A patent/HRP20041209A2/hr not_active Application Discontinuation
- 2003-06-26 AU AU2003280141A patent/AU2003280141A1/en not_active Abandoned
- 2003-06-26 RU RU2005101872/04A patent/RU2005101872A/ru not_active Application Discontinuation
- 2003-06-26 KR KR10-2004-7021262A patent/KR20050014888A/ko not_active Withdrawn
- 2003-06-26 EP EP03740352A patent/EP1527083A1/en not_active Withdrawn
- 2003-06-26 MX MXPA04012815A patent/MXPA04012815A/es not_active Application Discontinuation
- 2003-06-26 CN CNA038179660A patent/CN1671728A/zh active Pending
- 2003-06-26 BR BR0312428-2A patent/BR0312428A/pt not_active IP Right Cessation
- 2003-06-26 TW TW092117351A patent/TW200500376A/zh unknown
- 2003-06-26 JP JP2004516688A patent/JP2006501178A/ja active Pending
- 2003-06-26 WO PCT/EP2003/006749 patent/WO2004003002A1/en not_active Ceased
- 2003-06-26 PL PL03375197A patent/PL375197A1/xx not_active Application Discontinuation
- 2003-06-26 IL IL16593403A patent/IL165934A0/xx unknown
- 2003-06-26 CA CA002490253A patent/CA2490253A1/en not_active Abandoned
-
2004
- 2004-12-13 ZA ZA200410062A patent/ZA200410062B/xx unknown
- 2004-12-24 MA MA28022A patent/MA27465A1/fr unknown
-
2005
- 2005-01-25 NO NO20050398A patent/NO20050398L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20050014888A (ko) | 2005-02-07 |
| HRP20041209A2 (en) | 2005-08-31 |
| IL165934A0 (en) | 2006-01-15 |
| RU2005101872A (ru) | 2005-08-10 |
| TW200500376A (en) | 2005-01-01 |
| EP1527083A1 (en) | 2005-05-04 |
| EP1375508A1 (en) | 2004-01-02 |
| AR039697A1 (es) | 2005-03-09 |
| CA2490253A1 (en) | 2004-01-08 |
| CN1671728A (zh) | 2005-09-21 |
| AU2003280141A1 (en) | 2004-01-19 |
| BR0312428A (pt) | 2005-04-26 |
| NO20050398L (no) | 2005-01-25 |
| PL375197A1 (en) | 2005-11-28 |
| WO2004003002A1 (en) | 2004-01-08 |
| JP2006501178A (ja) | 2006-01-12 |
| ZA200410062B (en) | 2008-08-27 |
| MA27465A1 (fr) | 2005-08-01 |
| MXPA04012815A (es) | 2005-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2003132687A (ru) | Лечение диабета типа 2 ингибиторами дипептидилпептидазы iv | |
| PE20090964A1 (es) | Derivados de pirrolo[2,3-d]pirimidina como inhibidores de proteina quinasa b | |
| RU2004132204A (ru) | Имидазоконденсированные соединения | |
| RU2000129161A (ru) | Производное 1-[(1-замещенного-4-пиперидинил)метил]-4-пиперидина, способ его получения, фармацевтическая композиция, содержащая указанное соединение, и промежуточный продукт | |
| EA200601773A1 (ru) | Тетраазабензо[е]азуленовые производные и их аналоги | |
| RU2009135621A (ru) | Хинолиновые производные для лечения воспалительных заболеваний | |
| PE20060487A1 (es) | Derivados de 2-carbamida-4-feniltiazol como moduladores de la actividad de quimioquinas | |
| PE20060501A1 (es) | Compuestos de aminoheteroarilo enantiomericamente puros como inhibidores de proteina quinasa | |
| ATE425166T1 (de) | Amidderivate von 3-phenyldihydropyrimidoä4,5- düpyrimidinonen, deren herstellung und verwendung als pharmazeutische mittel | |
| CY1117576T1 (el) | Δινουκλεοτιδικα προφαρμακα | |
| JP2017165744A (ja) | ５−置換キナゾリノン誘導体、それを含む組成物、及びその使用方法 | |
| AR047076A1 (es) | Compuestos de pirrolotriazina como inhibidores de tirosina quinasas, composiciones farmaceuticas | |
| PE20060837A1 (es) | COMPUESTOS DE 3H-OXAZOLO Y 3H-TIAZOLO[4,5-d]PIRIMIDIN-2-ONA 3,5-DISUSTITUIDA Y 3,5,7-TRISUSTITUIDA Y PROFARMACOS DE LOS MISMOS | |
| AR038864A1 (es) | Inhibidores pirimidina y piridina biciclicos de la p38 quinasa | |
| MA27582A1 (fr) | Derives benzazepine pour le traitement de troubles neurologiques | |
| EA200600928A1 (ru) | Фармацевтически приемлемые соли хинолиноновых соединений с улучшенными фармацевтическими свойствами | |
| EA200601584A1 (ru) | Замещённые глюкопиранозилом бензольные производные, содержащие эти соединения лекарственные средства, их применение и способ их получения | |
| AR048376A1 (es) | C- glicosidos heterociclos fusionados sustituidos | |
| UA98966C2 (ru) | Производные бензазепина, пригодные для использования в качестве антагонистов вазопрессина | |
| EA200400953A1 (ru) | Замещённые пиридиноны в качестве модуляторов map-киназы p38 | |
| IS8503A (is) | Azatvíhringja heteróhringir sem kannabínóníð-viðtakastillar | |
| PE20080553A1 (es) | Ciclobuten-1,2-dionas 3,4-di-sustituidas como ligandos de receptores de quimiocinas cxc | |
| MX2023014630A (es) | Activadores de dimetoxifenilalquilamina de receptores de serotonina. | |
| CY1109808T1 (el) | Αρυλινδενο-πυριδινες και αρυλινδενο-πυριμιδινες και η χρηση τους ως ανταγωνιστων των υποδοχεων αδενοσινης α2α | |
| AR043259A1 (es) | Metodo para el tratamiento de insuficiencia cardiaca severa y medicamento para ello |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |